ICAM1 and COVID-19: As shown in Figure 2, the levels of CD62E, ICAM1, IL‐1 alpha, IL‐8, IP‐10, MCP‐1, and MIP‐1 beta were augmented in the COVID‐19 group while CD62P was greater in the non‐COVID‐19 group.